cached image

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Harper K, Brochu-Gaudreau K, Saucier C, M Dubois C. Hypoxia Downregulates LPP3 and Promotes the Spatial Segregation of ATX and LPP1 During Cancer Cell Invasion. Cancers. 11. PMID 31546971 DOI: 10.3390/Cancers11091403  0.371
2018 McManus S, Chababi W, Arsenault D, Dubois CM, Saucier C. Dissecting Oncogenic RTK Pathways in Colorectal Cancer Initiation and Progression. Methods in Molecular Biology (Clifton, N.J.). 1765: 27-42. PMID 29589299 DOI: 10.1007/978-1-4939-7765-9_2  0.453
2017 Chevrier M, Bobbala D, Villalobos-Hernandez A, Khan MG, Ramanathan S, Saucier C, Ferbeyre G, Geha S, Ilangumaran S. Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer. Bmc Cancer. 17: 157. PMID 28235401 DOI: 10.1186/S12885-017-3141-8  0.38
2017 Duclos CM, Champagne A, Carrier JC, Saucier C, Lavoie CL, Denault JB. Caspase-mediated proteolysis of the sorting nexin 2 disrupts retromer assembly and potentiates Met/hepatocyte growth factor receptor signaling. Cell Death Discovery. 3: 16100. PMID 28179995 DOI: 10.1038/Cddiscovery.2016.100  0.432
2017 Duclos CM, Champagne A, Carrier JC, Saucier C, Lavoie CL, Denault J. Abstract LB-018: Cleavage of SNX2 protein by initiator caspases promotes hepatocyte growth factor (MET) receptor tyrosine kinase signaling Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-018  0.487
2016 Bouchard G, Therriault H, Bujold R, Saucier C, Paquette B. Induction of interleukin-1β by mouse mammary tumor irradiation promotes triple negative breast cancer cells invasion and metastasis development. International Journal of Radiation Biology. 1-38. PMID 27935337 DOI: 10.1080/09553002.2017.1270471  0.302
2016 Villalobos-Hernandez A, Bobbala D, Kandhi R, Khan MG, Mayhue M, Dubois CM, Ferbeyre G, Saucier C, Ramanathan S, Ilangumaran S. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma. Prostate Cancer and Prostatic Diseases. PMID 27779203 DOI: 10.1038/Pcan.2016.50  0.412
2016 Rodriguez GM, Bobbala D, Serrano D, Mayhue M, Champagne A, Saucier C, Steimle V, Kufer TA, Menendez A, Ramanathan S, Ilangumaran S. NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8(+) T lymphocytes. Oncoimmunology. 5: e1151593. PMID 27471621 DOI: 10.1080/2162402X.2016.1151593  0.312
2016 Landry M, Pomerleau V, Saucier C. Non-canonical dynamic mechanisms of interaction between the p66Shc protein and Met receptor. The Biochemical Journal. PMID 27048591 DOI: 10.1042/Bcj20160249  0.551
2016 Beaurivage C, Champagne A, Tobelaim WS, Pomerleau V, Menendez A, Saucier C. SOCS1 in cancer: An oncogene and a tumor suppressor. Cytokine. PMID 26811119 DOI: 10.1016/J.Cyto.2016.01.005  0.366
2016 Yeganeh M, Gui Y, Kandhi R, Bobbala D, Tobelaim WS, Saucier C, Yoshimura A, Ferbeyre G, Ramanathan S, Ilangumaran S. Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver. Oncogene. PMID 26725321 DOI: 10.1038/Onc.2015.485  0.339
2015 Tobelaim WS, Beaurivage C, Champagne A, Pomerleau V, Simoneau A, Chababi W, Yeganeh M, Thibault P, Klinck R, Carrier JC, Ferbeyre G, Ilangumaran S, Saucier C. Tumour-promoting role of SOCS1 in colorectal cancer cells. Scientific Reports. 5: 14301. PMID 26391193 DOI: 10.1038/Srep14301  0.376
2015 Gui Y, Yeganeh M, Donates YC, Tobelaim WS, Chababi W, Mayhue M, Yoshimura A, Ramanathan S, Saucier C, Ilangumaran S. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma. Oncogene. PMID 25728680 DOI: 10.1038/Onc.2015.20  0.497
2014 Pomerleau V, Landry M, Bernier J, Vachon PH, Saucier C. Met receptor-induced Grb2 or Shc signals both promote transformation of intestinal epithelial cells, albeit they are required for distinct oncogenic functions. Bmc Cancer. 14: 240. PMID 24708867 DOI: 10.1186/1471-2407-14-240  0.491
2014 Haines E, Saucier C, Claing A. The adaptor proteins p66Shc and Grb2 regulate the activation of the GTPases ARF1 and ARF6 in invasive breast cancer cells. The Journal of Biological Chemistry. 289: 5687-703. PMID 24407288 DOI: 10.1074/Jbc.M113.516047  0.472
2014 Gui Y, Yeganeh M, Cepero-Donates Y, Ramanathan S, Saucier C, Ilangumaran S. Regulation of MET receptor signaling by SOCS1 and its implications for hepatocellular carcinoma. Current Pharmaceutical Design. 20: 2922-33. PMID 23944359 DOI: 10.2174/13816128113199990597  0.48
2014 Pomerleau V, Landry M, Saucier C. Tu1215 Novel Non-Canonical Modes of Interaction Between the Receptor Met and the p66 Protein Isoform of Shc and Its Duality of Functions in Intestinal Epithelial Cells Gastroenterology. 146: S-786. DOI: 10.1016/S0016-5085(14)62836-5  0.4
2013 Bouchard G, Bouvette G, Therriault H, Bujold R, Saucier C, Paquette B. Pre-irradiation of mouse mammary gland stimulates cancer cell migration and development of lung metastases. British Journal of Cancer. 109: 1829-38. PMID 24002607 DOI: 10.1038/Bjc.2013.502  0.328
2012 Gui Y, Chabadi W, Yeganeh M, Pomerleau V, Leblanc C, Ramanathan S, Saucier C, Ilangumaran S. 65 SOCS1 NEGATIVELY REGULATES THE HEPATOCYTE GROWTH FACTOR RECEPTOR MET VIA UBIQUITINATION AND PROTEASOMAL DEGRADATION Journal of Hepatology. 56: S29. DOI: 10.1016/S0168-8278(12)60079-8  0.433
2011 Gui Y, Yeganeh M, Ramanathan S, Leblanc C, Pomerleau V, Ferbeyre G, Saucier C, Ilangumaran S. SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes. Journal of Hepatology. 55: 1300-8. PMID 21703184 DOI: 10.1016/J.Jhep.2011.03.027  0.411
2010 Langlois MJ, Bergeron S, Bernatchez G, Boudreau F, Saucier C, Perreault N, Carrier JC, Rivard N. The PTEN phosphatase controls intestinal epithelial cell polarity and barrier function: role in colorectal cancer progression. Plos One. 5: e15742. PMID 21203412 DOI: 10.1371/Journal.Pone.0015742  0.375
2010 Bernier J, Chababi W, Pomerleau V, Saucier C. Oncogenic engagement of the Met receptor is sufficient to evoke angiogenic, tumorigenic, and metastatic activities in rat intestinal epithelial cells. American Journal of Physiology. Gastrointestinal and Liver Physiology. 299: G677-86. PMID 20539003 DOI: 10.1152/Ajpgi.00315.2009  0.519
2010 Chababi W, Pomerleau V, Bernier J, Saucier C. 173 Engagement of Shc-Dependent Signals by RTK Promotes In Vivo Tumorigenic and Metastatic Behaviors in Normal Intestinal Epithelial Cells Gastroenterology. 138: S-31. DOI: 10.1016/S0016-5085(10)60144-8  0.334
2009 Lemieux E, Bergeron S, Durand V, Asselin C, Saucier C, Rivard N. Constitutively active MEK1 is sufficient to induce epithelial-to-mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis. International Journal of Cancer. Journal International Du Cancer. 125: 1575-86. PMID 19462441 DOI: 10.1002/Ijc.24485  0.391
2009 Bernier J, Chababi W, Pomerleau V, Saucier C. S2041 Oncogenic Met Receptor Promotes Tumorigenesis and Metastases in Normal Intestinal Epithelial Cells Gastroenterology. 136: A-318. DOI: 10.1016/S0016-5085(09)61456-6  0.424
2008 Seiden-Long I, Navab R, Shih W, Li M, Chow J, Zhu CQ, Radulovich N, Saucier C, Tsao MS. Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells. Carcinogenesis. 29: 647-55. PMID 18192688 DOI: 10.1093/Carcin/Bgn009  0.561
2006 Mood K, Saucier C, Bong YS, Lee HS, Park M, Daar IO. Gab1 is required for cell cycle transition, cell proliferation, and transformation induced by an oncogenic met receptor. Molecular Biology of the Cell. 17: 3717-28. PMID 16775003 DOI: 10.1091/Mbc.E06-03-0244  0.63
2006 Ishimura A, Lee HS, Bong YS, Saucier C, Mood K, Park EK, Daar IO. Oncogenic Met receptor induces ectopic structures in Xenopus embryos. Oncogene. 25: 4286-99. PMID 16518409 DOI: 10.1038/sj.onc.1209463  0.445
2006 Mood K, Saucier C, Ishimura A, Bong YS, Lee HS, Park M, Daar IO. Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling. Journal of Cellular Physiology. 207: 271-85. PMID 16331688 DOI: 10.1002/Jcp.20564  0.651
2005 Abella JV, Peschard P, Naujokas MA, Lin T, Saucier C, Urbé S, Park M. Met/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation. Molecular and Cellular Biology. 25: 9632-45. PMID 16227611 DOI: 10.1128/Mcb.25.21.9632-9645.2005  0.632
2004 Saucier C, Khoury H, Lai KM, Peschard P, Dankort D, Naujokas MA, Holash J, Yancopoulos GD, Muller WJ, Pawson T, Park M. The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis. Proceedings of the National Academy of Sciences of the United States of America. 101: 2345-50. PMID 14983012 DOI: 10.1073/Pnas.0308065101  0.654
2003 Lock LS, Frigault MM, Saucier C, Park M. Grb2-independent recruitment of Gab1 requires the C-terminal lobe and structural integrity of the Met receptor kinase domain. The Journal of Biological Chemistry. 278: 30083-90. PMID 12766170 DOI: 10.1074/Jbc.M302675200  0.579
2002 Saucier C, Papavasiliou V, Palazzo A, Naujokas MA, Kremer R, Park M. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis. Oncogene. 21: 1800-11. PMID 11896612 DOI: 10.1038/Sj.Onc.1205261  0.622
1998 Saucier C, Morris SJ, Albert PR. Endogenous serotonin-2A and -2C receptors in Balb/c-3T3 cells revealed in serotonin-free medium: desensitization and down-regulation by serotonin. Biochemical Pharmacology. 56: 1347-57. PMID 9825734 DOI: 10.1016/S0006-2952(98)00244-5  0.349
1997 Saucier C, Albert PR. Identification of an endogenous 5-hydroxytryptamine2A receptor in NIH-3T3 cells: agonist-induced down-regulation involves decreases in receptor RNA and number. Journal of Neurochemistry. 68: 1998-2011. PMID 9109526 DOI: 10.1046/J.1471-4159.1997.68051998.X  0.402
1996 Albert PR, Lembo P, Storring JM, Charest A, Saucier C. The 5-HT1A receptor: signaling, desensitization, and gene transcription. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 14: 19-25. PMID 8719026 DOI: 10.1016/S0893-133X(96)80055-8  0.435
Show low-probability matches.